Translational Research Institute

November 6, 2015

UAMS Staff Expertise Helps Researcher Make History

ChaseYavondaC

Parker Kieber-Emmons

Nov. 6, 2015 | Behind the headlines of his breast cancer vaccine, now in a phase II clinical trial, UAMS’ Thomas Kieber-Emmons, Ph.D., tells a back story that inspires him and even draws applause from colleagues. Kieber-Emmons peppers the story with some significant numbers: 1, 6, 28, 1,500, 4,000. The story begins in 2005 with…

January 29, 2015

UAMS Startup Gets $14.5 Million to Develop Drug Therapies for Methamphetamine Users

Spencer Watson

January 29, 2015 | A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.


Previous page